Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01257191 · ClinicalTrials.gov registry record · Phase 1
A Study to Compare the Effects of Different Sized Particles on Cells in the Nose
A Phase 1 study of Hypersensitivity, Immediate and Atopic Hypersensitivity, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT01257191 is a Phase 1 study of Hypersensitivity, Immediate and Atopic Hypersensitivity that has completed, run by University of California, Los Angeles. The registered enrollment target is 25 participants, below the 243-participant average among 3 other Hypersensitivity, Immediate trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01257191, a Phase 1 study of Hypersensitivity, Immediate and Atopic Hypersensitivity, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to see how the type and size of particles found in air pollution affects inflammation in the nose in people who are skin test positive to at least one allergen. It has been observed that pollution makes allergies worse. It has also been suggested that very small particles may affect allergies more than larger particles.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Carbon Black
- DRUG Diesel Exhaust Particles
- DRUG Fine Concentrated Ambient Particles
- DRUG Ultrafine Concentrated Ambient Particles
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01257191
The ClinicalTrials.gov registry entry for NCT01257191 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 3 other Hypersensitivity, Immediate trials with a reported enrollment target (90% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Hypersensitivity, Immediate appearing as the primary indexed condition, and to 5 interventions - of which Saline is the first listed.
NCT01257191 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01257191 about?
NCT01257191 is a clinical study titled "A Study to Compare the Effects of Different Sized Particles on Cells in the Nose". The goal of this study is to see how the type and size of particles found in air pollution affects inflammation in the nose in people who are skin test positive to at least one allergen. It has been observed that pollution makes allergies worse. It has also been suggested that very small particles m...
What is the current status of trial NCT01257191?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2010-04. Estimated completion is 2012-01.
What conditions does trial NCT01257191 study?
This clinical trial studies the following conditions: Hypersensitivity, Immediate, Atopic Hypersensitivity.
What interventions are being tested in trial NCT01257191?
The interventions under investigation include: Saline (DRUG), Carbon Black (DRUG), Diesel Exhaust Particles (DRUG), Fine Concentrated Ambient Particles (DRUG), Ultrafine Concentrated Ambient Particles (DRUG).
Who is sponsoring clinical trial NCT01257191?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01257191 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersensitivity, Immediate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge
COMPLETED · NA
-
Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis
COMPLETED · Phase 3
-
Asthma Data Innovation Demonstration Project
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.